Black Diamond Therapeutics
BDTX
BDTX
84 hedge funds and large institutions have $66.3M invested in Black Diamond Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $103M → $66.3M (-$36.2M)
38% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 29
Holders
84
Holding in Top 10
–
Calls
$156K
Puts
$69K
Top Buyers
| 1 | +$846K | |
| 2 | +$775K | |
| 3 | +$398K | |
| 4 |
Morgan Stanley
New York
|
+$320K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$221K |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$1.28M | |
| 3 | -$1.08M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$574K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$528K |
